Matthew Korenberg - 30 Nov 2022 Form 4 Insider Report for LIGAND PHARMACEUTICALS INC (LGND)

Signature
/s/ Andrew Reardon, Attorney-in-Fact for Matthew E. Korenberg
Issuer symbol
LGND
Transactions as of
30 Nov 2022
Transactions value $
-$261,930
Form type
4
Filing time
01 Dec 2022, 20:42:52 UTC
Previous filing
03 Nov 2022
Next filing
15 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGND Common Stock Tax liability -$261,929 -3,593 -4.2% $72.9 82,428 30 Nov 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.